Copyright
©2006 Baishideng Publishing Group Co.
World J Gastroenterol. Jul 14, 2006; 12(26): 4195-4198
Published online Jul 14, 2006. doi: 10.3748/wjg.v12.i26.4195
Published online Jul 14, 2006. doi: 10.3748/wjg.v12.i26.4195
Figure 1 Continuously monitoring the development of signals in parallel standards and samples results in a series of amplification curves.
The amplification of a 198 bp fragment of the generated hTERT cDNA was identified. (A: Signal from RMCCA1; B: Signal from HuCCA1; C, D: Signals from serum of cholangiocarcinoma patients; E, F: Signals from serum of benign biliary tract patients).
- Citation: Leelawat K, Leelawat S, Ratanachu-Ek T, Trubwongchareon S, Wannaprasert J, Tripongkaruna S, Chantawibul S, Tepaksorn P. Circulating hTERT mRNA as a tumor marker in cholangiocarcinoma patients. World J Gastroenterol 2006; 12(26): 4195-4198
- URL: https://www.wjgnet.com/1007-9327/full/v12/i26/4195.htm
- DOI: https://dx.doi.org/10.3748/wjg.v12.i26.4195